Table 1.
Socioeconomic, clinical characteristics and adherence to secondary prevention of patients with ACS, according to the type of healthcare, Aracaju, Sergipe, Brazil.
| Number of Valid Patients |
Type of Healthcare |
|||
|---|---|---|---|---|
| Categorical Variables | (%) | SUS (%) | PHCS (%) | p |
| Age group (Years)1 | ||||
| from 18 to 49 | 75 (12.9) | 51 (19.9) | 24 (7.4) | |
| from 50 to59 | 144 (24.8) | 68 (26.6) | 76 (23.4) | |
| from 60 to 69 | 197 (33.9) | 88 (34.4) | 109 (33.5) | <0.001 |
| from 70 to79 | 108 (18.6) | 38 (14.8) | 70 (21.5) | |
| ≥ 80 | 57 (9.8) | 11 (4.3) | 46 (14.2) | |
| Sex1 | ||||
| Male | 370 (63.7) | 181 (70.7) | 189 (58.2) | <0.002 |
| Female | 211 (36.3) | 75 (29.3) | 136 (41.8) | |
| Schooling (Years)1 | ||||
| No schooling or < 1 year | 44 (7.6) | 32 (12.5) | 12 (3.7) | |
| from 1 to 3 | 84 (14.5) | 64 (25.0) | 20 (6.1) | <0.001 |
| from 4 to 8 | 178 (30.6) | 99 (38.7) | 79 (24.3) | |
| 9 years or more | 275 (47.3) | 61 (23.8) | 214 (65.9) | |
| Familiar Income Per Capita (MW)2 | ||||
| ≤ 1 | 248 (43.0) | 196 (76.9) | 52 (16.2) | |
| > 1 and ≤ 3 | 216 (37.5) | 54 (21.1) | 162 (50.5) | <0.001 |
| > 3 and ≤ 5 | 50 (8.7) | 3 (1.2) | 47 (14.6) | |
| > 5 | 62 (10.8) | 2 (0.8) | 60 (18.7) | |
| ABEP Classification 1 | ||||
| Class A | 50 (8.6) | 3 (1.2) | 47 (14.5) | |
| Clases B1 and B2 | 179 (30.8) | 26 (10.1) | 153 (47.1) | <0.001 |
| Clases C1 and C2 | 207 (35.6) | 101 (39.5) | 106 (32.6) | |
| Clases D – E | 145 (25.0) | 126 (49.2) | 19 (5.8) | |
| ACS Classification 1 | ||||
| UA | 101 (17.4) | 20 (7.8) | 81 (24.9) | |
| NSTEMI | 213 (36.7) | 47 (18.4) | 166 (51.1) | <0.001 |
| STEMI | 267 (45.9) | 189 (73.8) | 78 (24.0) | |
| Systemic Arterial Hypertension1 | 464 (79.9) | 194 (75.8) | 270 (83.1) | 0.037 |
| Diabetes Mellitus1 | 208 (35.8) | 76 (29.7) | 132 (40.6) | 0.008 |
| Dyslipidemia 1 | 322 (55.4) | 104 (40.6) | 218 (67.1) | <0.001 |
| Overweight2 | 390 (67.7) | 153 (60.5) | 237 (73.4) | 0.001 |
| Abdominal Obesity 3 | 428 (75.3) | 171 (68.1) | 257 (81.1) | <0.001 |
| Sedentarism1 | 311 (53.5) | 131 (51.2) | 180 (55.4) | 0.353 |
| Alcoholism1 | 70 (12.0) | 39 (15.2) | 31 (9.5) | 0.049 |
| Smoking1 | ||||
| No | 268 (46.1) | 100 (39.1) | 168 (51.7) | <0.001 |
| Yes | 99 (17.0) | 63 (24.6) | 36 (11.1) | |
| Ex-smoker | 214 (36.9) | 93 (36.3) | 121 (37.2) | |
| Hospitalization time (Days)4 | 555 (100.0) | 11.44 (11.6)⸸ | 9.42 (10.6)⸸ | <0.001A |
| Prescribed Medications at Discharge 4 | 555 (100.0) | 6.67 (1.3)⸸ | 7.20 (1.5)⸸ | <0.001A |
| No medical care 30 days after ACS5 | 63 (12.1) | 45 (19.6) | 18 (6.2) | <0.001 |
| No medical care 180 days after ACS6 | 47 (9.6) | 31 (14.7) | 16 (5.8) | 0.002 |
| Presence of CV outcomes 180 days post-ACS7 | 581 (100.0) | 45 (17.6) | 54 (16.6) | 0.845 |
| ACS | 32 (12.5) | 36 (11.1) | 0.689 | |
| Stroke | 5 (2.0) | 4 (1.2) | 0.516 | |
| CHF | 7 (2.7) | 8 (2.5) | 0.987 | |
| Cardiac Arrest | 1 (0.4) | 6 (1.8) | 0.141 | |
| Rehospitalization8 | 513 (100.0) | 29 (13.0) | 51 (17.6) | 0.188 |
| Adherence to Secondary Prevention 30 days post-ACS | 519 (100.0) | |||
| Adherence to pharmacotherapy | ||||
| No | 180 (34.7) | 99 (43.0) | 81 (28.0) | 0.001 |
| Yes | 339 (65.3) | 131 (57.0) | 208 (72.0) | |
| Adherence to Acetylsalicylic Acid9 | 478 (96.0) | 204 (94.4) | 274 (97.2) | 0.193 |
| Adherence to Other Antiplatelets9 | 481 (93.9) | 206 (90.7) | 275 (96.5) | 0.012 |
| Adherence to Statins9 | 437 (89.4) | 175 (83.3) | 262 (93.9) | <0.001 |
| Adherence to β-Blockers9 | 432 (92.7) | 181 (88.7) | 251 (95.8) | 0.006 |
| Adherence to ACEI/ARB9 | 409 (90.9) | 169 (87.1) | 240 (93.8) | 0.024 |
| Smoking Cessation | ||||
| Smoker | 17 (3.3) | 7 (3.0) | 10 (3.5) | 0.986 |
| Non smoker | 502 (96.7) | 223 (97.0) | 279 (96.5) | |
| Adherence to Secondary Prevention 180 days post-ACS | 488 (100.0) | |||
| Adherence to pharmacotherapy | ||||
| No | 161 (33.0) | 88 (41.7) | 73 (26.4) | 0.001 |
| Yes | 327 (67.0) | 123 (58.3) | 204 (73.6) | |
| Adherence to Acetylsalicylic Acid9 | 434 (92.5) | 174 (88.3) | 260 (95.6) | 0.006 |
| Adherence to Other Antiplatelets9 | 428 (88.6) | 172 (82.3) | 256 (93.4) | <0.001 |
| Adherence to Statins9 | 388 (83.3) | 143 (72.6) | 245 (91.1) | <0.001 |
| Adherence to β-Blockers9 | 392 (88.9) | 157 (83.1) | 235 (93.3) | 0.001 |
| Adherence to ACEI/ARB9 | 357 (84.6) | 130 (74.3) | 227 (91.9) | <0.001 |
| Smoking Cessation | ||||
| Smoker | 25 (5.1) | 14 (6.6) | 11 (4.0) | 0.264 |
| Non smoker | 463 (94.9) | 197 (93.4) | 266 (96.0) | |
| Physical Activity | ||||
| Sedentary | 280 (57.4) | 133 (63.0) | 147 (53.1) | 0.034 |
| Active | 208 (42.6) | 78 (37.0) | 130 (46.9) | |
ACS = Acute Coronary Sindrome; MW = Minimum Wage; ABEP = Brazilian Asssociation of Research Companies (2015); UA = Unstable Angina; NSTEMI = non-ST elevation myocardial infarction; STEMI = ST elevation myocardial infarction; CV = Cardiovascular; CHF = Congestive Heart Failure; ACEI = Angiotensin Converting Enzyme Inhibitors; ARB = Angiotensin II Receptor Blockers; p = Fisher’s Exact Test or Pearson’s Chi-square Test; A = Mann-Whitney Test; ⸸Mean (±SD); 1 = 581; 2 = 576; 3 = 568; 4 = Patients excluded because of intra-hospital death (26 patients); 5 = 519; 6 = 488; 7 = Total number of patients admitted in the study, since new outcomes could arise during hospitalization of ACS; 8 = Patients who died in the hospital and sample losses were excluded (68 patients); 9 = Patients Indicated to use medication at hospital discharge.